Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Riociguat

EU orphan designation number: EU/3/14/1299   
Active ingredient: Riociguat
Indication: Treatment of systemic sclerosis
Sponsor: Bayer Pharma AG
Müllerstrasse 178, 13353 Berlin, Deutschland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page
Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
31/07/2014 Orphan designation EMA/OD/044/14 (2014)5524 of 29/07/2014